Company Overview - Kingmed Diagnostics, established on May 26, 2006, is located in Guangzhou, Guangdong Province, and was listed on September 8, 2017. The company primarily provides diagnostic services to over 23,000 medical institutions nationwide [3]. Stock Performance - As of August 22, Kingmed Diagnostics' stock price increased by 2.14%, reaching CNY 31.00 per share, with a total market capitalization of CNY 14.36 billion. The trading volume was CNY 97.27 million, with a turnover rate of 0.69% [1]. - Year-to-date, the stock price has risen by 16.32%, with a 2.79% increase over the last five trading days, a 2.31% increase over the last 20 days, and a 4.87% increase over the last 60 days [2]. Financial Performance - For the first quarter of 2025, Kingmed Diagnostics reported a revenue of CNY 1.467 billion, representing a year-on-year decrease of 20.35%. The company has distributed a total of CNY 2.545 billion in dividends since its A-share listing, with CNY 1.647 billion distributed over the past three years [3]. Shareholder Information - As of March 31, 2025, the number of shareholders increased by 20.88% to 44,000, with an average of 10,460 circulating shares per shareholder, a decrease of 17.28% from the previous period. The second-largest shareholder, Hong Kong Central Clearing Limited, holds 33.11 million shares, down by 11.35 million shares from the previous period [3]. Market Activity - Kingmed Diagnostics has appeared on the "Dragon and Tiger List" once this year, with the most recent appearance on February 7 [3]. - The company has seen a net inflow of CNY 4.74 million in principal funds, with significant buying activity from large orders [1].
金域医学涨2.14%,成交额9727.46万元,主力资金净流入473.87万元